1. Isolation of a Human Betaretrovirus from Patients with Primary Biliary Cholangitis.
- Author
-
Goubran, Mariam, Wang, Weiwei, Indik, Stanislav, Faschinger, Alexander, Wasilenko, Shawn T., Bintner, Jasper, Carpenter, Eric J., Zhang, Guangzhi, Nuin, Paulo, Macintyre, Georgina, Wong, Gane K.-S., and Mason, Andrew L.
- Subjects
CHOLANGITIS ,MOUSE mammary tumor virus ,LYMPHOID tissue ,VIRUS diseases ,CANCER genes ,IN situ hybridization ,BREAST ,AXILLA - Abstract
A human betaretrovirus (HBRV) has been linked with the autoimmune liver disease, primary biliary cholangitis (PBC), and various cancers, including breast cancer and lymphoma. HBRV is closely related to the mouse mammary tumor virus, and represents the only exogenous betaretrovirus characterized in humans to date. Evidence of infection in patients with PBC has been demonstrated through the identification of proviral integration sites in lymphoid tissue, the major reservoir of infection, as well as biliary epithelium, which is the site of the disease process. Accordingly, we tested the hypothesis that patients with PBC harbor a transmissible betaretrovirus by co-cultivation of PBC patients' lymph node homogenates with the HS578T breast cancer line. Because of the low level of HBRV replication, betaretrovirus producing cells were subcloned to optimize viral isolation and production. Evidence of infection was provided by electron microscopy, RT-PCR, in situ hybridization, cloning of the HBRV proviral genome and demonstration of more than 3400 integration sites. Further evidence of viral transmissibility was demonstrated by infection of biliary epithelial cells. While HBRV did not show a preference for integration proximal to specific genomic features, analyses of common insertion sites revealed evidence of integration proximal to cancer associated genes. These studies demonstrate the isolation of HBRV with features similar to mouse mammary tumor virus and confirm that patients with PBC display evidence of a transmissible viral infection. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF